The ASX 200 index experienced a significant decline on Monday, driven by a sharp increase in oil prices amid escalating tensions in the Middle East.
While such market corrections can be concerning in the immediate term, they are often viewed retrospectively as exceptional opportunities for investment.
With this perspective, here are 10 ASX 200-listed stocks that may be worthy of consideration following the recent market selloff.
Cochlear Ltd (ASX: COH)
Cochlear is a world leader in implantable hearing solutions. Its products enable individuals with significant hearing impairment to regain auditory function. Given the ageing global demographic and robust demand for hearing aids, Cochlear possesses substantial long-term growth potential.
CSL Ltd (ASX: CSL)
CSL ranks among Australia's most prominent healthcare corporations. Its plasma-derived therapies and vaccines divisions deliver critical treatments to patients worldwide. Demand for the company's biotechnological products is projected to increase steadily with expanding global healthcare requirements. Although recent performance has been below expectations, patience with this ASX 200 stock could be rewarding.
Goodman Group (ASX: GMG)
Goodman Group specializes in the development and management of logistics facilities and data infrastructure in key international cities. Its warehouse assets are integral to e-commerce supply chains, while its data centre projects capitalize on the rapid expansion of cloud computing and artificial intelligence.
Light & Wonder Inc. (ASX: LNW)
Light & Wonder is another ASX 200 stock to monitor. It is an international gaming technology firm with operations spanning casino, digital, and social gaming sectors. Its diverse portfolio of games and platforms offers exposure to the expanding global gaming and entertainment market.
Pro Medicus Ltd (ASX: PME)
Pro Medicus may present an opportunity after recent price weakness. The company develops medical imaging software utilized by hospitals and healthcare providers globally. Its Visage platform is widely recognized as one of the most sophisticated radiology imaging systems available, facilitating significant contract wins and sustained growth.
REA Group Ltd (ASX: REA)
REA Group operates Australia's premier online property portal, realestate.com.au. Its market dominance affords it strong pricing power and recurring revenue streams from property listings and ancillary services.
ResMed Inc. (ASX: RMD)
ResMed focuses on manufacturing devices and software for treating sleep apnoea and other respiratory disorders. With millions of cases remaining undiagnosed globally, there is considerable long-term demand for the company's sleep therapy solutions.
TechnologyOne Ltd (ASX: TNE)
TechnologyOne is a leading provider of enterprise software for government, education, and large corporate clients. Its shift to a cloud-based software-as-a-service model has enhanced recurring revenue and improved customer loyalty.
WiseTech Global Ltd (ASX: WTC)
WiseTech Global creates logistics software for freight forwarders and international supply chains. Its CargoWise platform assists businesses in managing complex cross-border trade operations, positioning the company to benefit from the long-term growth in global logistics.
Xero Ltd (ASX: XRO)
A final ASX 200 stock that could be a compelling purchase is Xero. It offers cloud-based accounting software tailored for small and medium-sized enterprises. With a multi-million subscriber base across various markets, the company continues to broaden its suite of financial tools and services. Given an estimated total addressable market of 100 million businesses, its growth trajectory appears extensive.
